Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients

OBJECTIVE: Linc00665 is a novel long non-coding RNA that can promote the progression of breast cancer, but its value in predicting the efficacy of neoadjuvant chemotherapy (NAC) for breast cancer has not been reported. We aim to analyze the correlation between Linc00665 expression and pathological c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Dai, Huijuan, Sheng, Xiaonan, Sha, Rui, Peng, Jing, Yang, Fan, Zhou, Liheng, Lin, Yanping, Xu, Yaqian, Zhang, Shan, Yin, Wenjin, Lu, Jinsong
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961084/
https://ncbi.nlm.nih.gov/pubmed/33738251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.604319
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados